Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

G-protein-coupled receptor 41 in cardiomyocytes: Effect of butyrate on intracellular Ca ²⁺ and sarcomere shortening.

Autor: Yao Y; Department of Anesthesiology, Peking University Third Hospital, Beijing, China.; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Yang X; Department of Anesthesiology, Qilu Hospital of Shandong University, Jinan, China.; Department of Anesthesiology, School of Medicine, University of Maryland, Baltimore, Maryland, USA., Moore BN; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Zhu T; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Lester L; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Johns RA; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Pluznick JL; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Gao WD; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Publikováno v: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2024 Dec 15; Vol. 38 (23), pp. e70207.

Prospects for Leveraging the Microbiota as Medicine for Hypertension.

Autor: Durgan DJ; Department of Integrative Physiology and Anesthesiology, Baylor College of Medicine, Houston, TX (D.J.D.)., Zubcevic J; Center for Hypertension and Precision Medicine, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Microbiome Consortium, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.)., Vijay-Kumar M; Center for Hypertension and Precision Medicine, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Microbiome Consortium, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.)., Yang T; Center for Hypertension and Precision Medicine, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Microbiome Consortium, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.)., Manandhar I; Center for Hypertension and Precision Medicine, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Microbiome Consortium, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.)., Aryal S; Center for Hypertension and Precision Medicine, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Microbiome Consortium, Toledo, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.).; Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, OH (J.Z., M.V.-K., T.Y., I.M., S.A., B.J.)., Muralitharan RR; Hypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia (R.R.M., F.Z.M.).; Victorian Heart Institute, Monash University, Melbourne, Australia (R.R.M., F.Z.M.).; Baker Heart and Diabetes Institute, Melbourne, Australia (R.R.M., F.Z.M.)., Li HB; Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, PR China (H.-B.L., Y.L.)., Li Y; Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, PR China (H.-B.L., Y.L.)., Abais-Battad JM; Department of Physiology, Medical College of Georgia at Augusta University (J.M.A.-B.)., Pluznick JL; Department of Physiology, Johns Hopkins School of Medicine, Baltimore, MD (J.L.P.)., Muller DN; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany (D.N.M.).; Experimental and Clinical Research Center, a cooperation of Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Germany (D.N.M.).; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany (D.N.M.).; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany (D.N.M.)., Marques FZ; Hypertension Research Laboratory, School of Biological Sciences, Monash University, Melbourne, Australia (R.R.M., F.Z.M.).; Victorian Heart Institute, Monash University, Melbourne, Australia (R.R.M., F.Z.M.).; Baker Heart and Diabetes Institute, Melbourne, Australia (R.R.M., F.Z.M.)., Joe B; Department of Integrative Physiology and Anesthesiology, Baylor College of Medicine, Houston, TX (D.J.D.).

Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 May; Vol. 81 (5), pp. 951-963. Date of Electronic Publication: 2024 Apr 17.